Microsurgical Thrombectomy: where the ancient art meets the new era

Author:

Ota Nakao1,Benet Arnau2,Kusdiansah Muhammad1,Miyoshi Norio1,Haraguchi Kenichi1,Noda Kosumo1,Lawton Michael T2,Tanikawa Rokuya1

Affiliation:

1. Sapporo Teishinkai Hospital

2. Barrow Neurological Institute

Abstract

Abstract Background Mechanical thrombectomy (MT) is the leading treatment for acute large vessel occlusion (LVO). However, surgical thrombectomy (ST) may have a role in well selected LVO patients where MT failed to re-establish flow, the endovascular route is inaccessible, or where MT is a financially prohibitive or absent option(developing and poor countries). We compared the efficacy and efficiency between ST and MT, and described our operative experience and its potential application in the developing world. Methods Clinical outcomes, procedural times and efficacy of treatment were compared between the MT and ST of acute LVO between 2012 and 2022. Propensity score-matched analysis was also conducted to compare MT and ST. Results One-hundred nine patients fulfilled the study criteria (77MTs vs 32STs). Factors driving outcome were age (aOR:0.95, 95%CI, 0.91-0.98), hemisphere side (aOR:0.38, 95%CI, 0.15-0.96), DWI-ASPECT (aOR:1.39, 95%CI, 1.09-1.77) at presentation by the multivariate analysis. Times from door-start of procedure(P=0.45), and start of procedure-recanalization(P=0.13) were similar between treatment options. Propensity score-matched analysis found no significant difference for 2 treatment methods about time of door to recanalization(P=0.155) and outcome(P=0.221). Conclusions The prognosticator of thrombectomy for acute LVO in patients with successful recanalization were age, affected hemisphere side and DWI-ASPECT score. Our evidence shows that the efficacy of ST is similar to that of MT. There should be a place of ST for cases of mechanical failure or tandem cervical ICA and MCA occlusion. ST may be a temporizing LVO treatment option in healthcare systems where MT is inexistent or financially prohibitive to patients.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3